APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rapid Influenza Diagnostic Test (RIDT)

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Selected research

Market Analysis & Forecast

Global Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast 2026-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchRapid Influenza Diagnostic Test (RIDT) Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Rapid Influenza Diagnostic Test (RIDT) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Rapid Influenza Diagnostic Test (RIDT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rapid Influenza Diagnostic Test (RIDT) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Rapid Influenza Diagnostic Test (RIDT) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Americas is the largest Rapid Influenza Diagnostic Test (RIDT) market with about 58% market share. Europe is follower, accounting for about 25% market share.

The key players are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy etc. Top 3 companies occupied about 49% market share.

Read the full market overview

Report Includes

This report presents an overview of global market for Rapid Influenza Diagnostic Test (RIDT), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rapid Influenza Diagnostic Test (RIDT), also provides the revenue of main regions and countries. Of the upcoming market potential for Rapid Influenza Diagnostic Test (RIDT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rapid Influenza Diagnostic Test (RIDT) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rapid Influenza Diagnostic Test (RIDT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Rapid Influenza Diagnostic Test (RIDT) revenue, projected growth trends, production technology, application and end-user industry.

Rapid Influenza Diagnostic Test (RIDT) Segment by Company

BD

Abbot (Alere)

Quidel

Roche

Thermo Fisher Scientific

Meridian Bioscience

Analytik Jena

Princeton BioMeditech Corporation

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

DiaSorin (Focus Diagnostics)

Wondfo

Beijing Wantai Biological Pharmacy

Rapid Influenza Diagnostic Test (RIDT) Segment by Type

Digital RIDTs

Conventional RIDT

Rapid Influenza Diagnostic Test (RIDT) Segment by Application

Hospitals

POCT

Others

Rapid Influenza Diagnostic Test (RIDT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid Influenza Diagnostic Test (RIDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rapid Influenza Diagnostic Test (RIDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid Influenza Diagnostic Test (RIDT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Rapid Influenza Diagnostic Test (RIDT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Rapid Influenza Diagnostic Test (RIDT) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rapid Influenza Diagnostic Test (RIDT) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Digital RIDTs Major Player Table 3. Conventional RIDT Major Player Table 4. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. POCT Major Player Table 7. Others Major Player Table 8. Rapid Influenza Diagnostic Test (RIDT) Industry Trends Table 9. Rapid Influenza Diagnostic Test (RIDT) Industry Drivers Table 10. Rapid Influenza Diagnostic Test (RIDT) Industry Opportunities and Challenges Table 11. Rapid Influenza Diagnostic Test (RIDT) Industry Restraints Table 12. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Region (2021-2026) Table 15. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Region (2027-2032) Table 17. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Players (2021-2026) Table 19. Global Rapid Influenza Diagnostic Test (RIDT) Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Rapid Influenza Diagnostic Test (RIDT) Key Players Headquarters & Area Served Table 21. Global Rapid Influenza Diagnostic Test (RIDT) Players, Product Type & Application Table 22. Global Rapid Influenza Diagnostic Test (RIDT) Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Rapid Influenza Diagnostic Test (RIDT) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2021-2026) Table 29. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2027-2032) Table 30. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2021-2026) Table 34. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2027-2032) Table 35. BD Company Information Table 36. BD Business Overview Table 37. BD Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. BD Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 39. BD Recent Development Table 40. Abbot (Alere) Company Information Table 41. Abbot (Alere) Business Overview Table 42. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 44. Abbot (Alere) Recent Development Table 45. Quidel Company Information Table 46. Quidel Business Overview Table 47. Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Quidel Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 49. Quidel Recent Development Table 50. Roche Company Information Table 51. Roche Business Overview Table 52. Roche Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Roche Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 54. Roche Recent Development Table 55. Thermo Fisher Scientific Company Information Table 56. Thermo Fisher Scientific Business Overview Table 57. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 59. Thermo Fisher Scientific Recent Development Table 60. Meridian Bioscience Company Information Table 61. Meridian Bioscience Business Overview Table 62. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 64. Meridian Bioscience Recent Development Table 65. Analytik Jena Company Information Table 66. Analytik Jena Business Overview Table 67. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 69. Analytik Jena Recent Development Table 70. Princeton BioMeditech Corporation Company Information Table 71. Princeton BioMeditech Corporation Business Overview Table 72. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 74. Princeton BioMeditech Corporation Recent Development Table 75. BioMerieux Company Information Table 76. BioMerieux Business Overview Table 77. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 79. BioMerieux Recent Development Table 80. Sekisui Diagnostics Company Information Table 81. Sekisui Diagnostics Business Overview Table 82. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 84. Sekisui Diagnostics Recent Development Table 85. Response Biomedical Company Information Table 86. Response Biomedical Business Overview Table 87. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 88. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 89. Response Biomedical Recent Development Table 90. SA Scientific Company Information Table 91. SA Scientific Business Overview Table 92. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 93. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 94. SA Scientific Recent Development Table 95. DiaSorin (Focus Diagnostics) Company Information Table 96. DiaSorin (Focus Diagnostics) Business Overview Table 97. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 98. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 99. DiaSorin (Focus Diagnostics) Recent Development Table 100. Wondfo Company Information Table 101. Wondfo Business Overview Table 102. Wondfo Rapid Influenza Diagnostic Test (RIDT) Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 103. Wondfo Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 104. Wondfo Recent Development Table 105. Beijing Wantai Biological Pharmacy Company Information Table 106. Beijing Wantai Biological Pharmacy Business Overview Table 107. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 108. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product Portfolio Table 109. Beijing Wantai Biological Pharmacy Recent Development Table 110. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (US$ Million) & (2027-2032) Table 124. China Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026) & (US$ Million) Table 125. China Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032) & (US$ Million) Table 126. China Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026) & (US$ Million) Table 127. China Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Rapid Influenza Diagnostic Test (RIDT) Image Figure 2. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Digital RIDTs Image Figure 5. Conventional RIDT Image Figure 6. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. POCT Image Figure 10. Others Image Figure 11. Global Rapid Influenza Diagnostic Test (RIDT) Market Size (US$ Million) & (2021-2032) Figure 12. Global Rapid Influenza Diagnostic Test (RIDT) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Rapid Influenza Diagnostic Test (RIDT) Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2021-2032) Figure 19. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2021-2032) Figure 22. North America Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032) Figure 24. North America Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032) Figure 25. North America Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Country (2021-2032) Figure 26. United States Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032) Figure 31. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032) Figure 32. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Country (2021-2032) Figure 33. Germany Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032) Figure 43. China Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032) Figure 44. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032) Figure 46. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032) Figure 47. Asia Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Region (2021-2032) Figure 48. Japan Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032) Figure 56. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032) Figure 57. SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Country (2021-2032) Figure 58. Brazil Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Rapid Influenza Diagnostic Test (RIDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Digital RIDTs
  • Conventional RIDT
Applications
  • Hospitals
  • POCT
  • Others
Companies covered
  • BD
  • Abbot (Alere)
  • Quidel
  • Roche
  • Thermo Fisher Scientific
  • Meridian Bioscience
  • Analytik Jena
  • Princeton BioMeditech Corporation
  • BioMerieux
  • Sekisui Diagnostics
  • Response Biomedical
  • SA Scientific
  • DiaSorin (Focus Diagnostics)
  • Wondfo
  • Beijing Wantai Biological Pharmacy

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rapid Influenza Diagnostic Test (RIDT) Market by Type
  3. 1.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Digital RIDTs
  5. 1.2.3 Conventional RIDT
  6. 1.3 Rapid Influenza Diagnostic Test (RIDT) Market by Application
  7. 1.3.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 POCT
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Rapid Influenza Diagnostic Test (RIDT) Market Dynamics
  1. 2.1 Rapid Influenza Diagnostic Test (RIDT) Industry Trends
  2. 2.2 Rapid Influenza Diagnostic Test (RIDT) Industry Drivers
  3. 2.3 Rapid Influenza Diagnostic Test (RIDT) Industry Opportunities and Challenges
  4. 2.4 Rapid Influenza Diagnostic Test (RIDT) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Perspective (2021-2032)
  2. 3.2 Global Rapid Influenza Diagnostic Test (RIDT) Growth Trends by Region
  3. 3.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2021-2026)
  5. 3.2.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Players
  2. 4.1.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Players (2021-2026)
  3. 4.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Rapid Influenza Diagnostic Test (RIDT) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rapid Influenza Diagnostic Test (RIDT) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Rapid Influenza Diagnostic Test (RIDT) Key Players Headquarters & Area Served
  7. 4.4 Global Rapid Influenza Diagnostic Test (RIDT) Players, Product Type & Application
  8. 4.5 Global Rapid Influenza Diagnostic Test (RIDT) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Rapid Influenza Diagnostic Test (RIDT) Market CR5 and HHI
  11. 4.6.3 2025 Rapid Influenza Diagnostic Test (RIDT) Tier 1, Tier 2, and Tier 3
5 Rapid Influenza Diagnostic Test (RIDT) Market Size by Type
  1. 5.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2032)
  3. 5.3 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2021-2032)
6 Rapid Influenza Diagnostic Test (RIDT) Market Size by Application
  1. 6.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2032)
  3. 6.3 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BD
  2. 7.1.1 BD Company Information
  3. 7.1.2 BD Business Overview
  4. 7.1.3 BD Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BD Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  6. 7.1.5 BD Recent Developments
  7. 7.2 Abbot (Alere)
  8. 7.2.1 Abbot (Alere) Company Information
  9. 7.2.2 Abbot (Alere) Business Overview
  10. 7.2.3 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  12. 7.2.5 Abbot (Alere) Recent Developments
  13. 7.3 Quidel
  14. 7.3.1 Quidel Company Information
  15. 7.3.2 Quidel Business Overview
  16. 7.3.3 Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Quidel Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  18. 7.3.5 Quidel Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Roche Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Thermo Fisher Scientific
  26. 7.5.1 Thermo Fisher Scientific Company Information
  27. 7.5.2 Thermo Fisher Scientific Business Overview
  28. 7.5.3 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  30. 7.5.5 Thermo Fisher Scientific Recent Developments
  31. 7.6 Meridian Bioscience
  32. 7.6.1 Meridian Bioscience Company Information
  33. 7.6.2 Meridian Bioscience Business Overview
  34. 7.6.3 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  36. 7.6.5 Meridian Bioscience Recent Developments
  37. 7.7 Analytik Jena
  38. 7.7.1 Analytik Jena Company Information
  39. 7.7.2 Analytik Jena Business Overview
  40. 7.7.3 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  42. 7.7.5 Analytik Jena Recent Developments
  43. 7.8 Princeton BioMeditech Corporation
  44. 7.8.1 Princeton BioMeditech Corporation Company Information
  45. 7.8.2 Princeton BioMeditech Corporation Business Overview
  46. 7.8.3 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  48. 7.8.5 Princeton BioMeditech Corporation Recent Developments
  49. 7.9 BioMerieux
  50. 7.9.1 BioMerieux Company Information
  51. 7.9.2 BioMerieux Business Overview
  52. 7.9.3 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  54. 7.9.5 BioMerieux Recent Developments
  55. 7.10 Sekisui Diagnostics
  56. 7.10.1 Sekisui Diagnostics Company Information
  57. 7.10.2 Sekisui Diagnostics Business Overview
  58. 7.10.3 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  60. 7.10.5 Sekisui Diagnostics Recent Developments
  61. 7.11 Response Biomedical
  62. 7.11.1 Response Biomedical Company Information
  63. 7.11.2 Response Biomedical Business Overview
  64. 7.11.3 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  66. 7.11.5 Response Biomedical Recent Developments
  67. 7.12 SA Scientific
  68. 7.12.1 SA Scientific Company Information
  69. 7.12.2 SA Scientific Business Overview
  70. 7.12.3 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  72. 7.12.5 SA Scientific Recent Developments
  73. 7.13 DiaSorin (Focus Diagnostics)
  74. 7.13.1 DiaSorin (Focus Diagnostics) Company Information
  75. 7.13.2 DiaSorin (Focus Diagnostics) Business Overview
  76. 7.13.3 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  77. 7.13.4 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  78. 7.13.5 DiaSorin (Focus Diagnostics) Recent Developments
  79. 7.14 Wondfo
  80. 7.14.1 Wondfo Company Information
  81. 7.14.2 Wondfo Business Overview
  82. 7.14.3 Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Wondfo Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  84. 7.14.5 Wondfo Recent Developments
  85. 7.15 Beijing Wantai Biological Pharmacy
  86. 7.15.1 Beijing Wantai Biological Pharmacy Company Information
  87. 7.15.2 Beijing Wantai Biological Pharmacy Business Overview
  88. 7.15.3 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product Portfolio
  90. 7.15.5 Beijing Wantai Biological Pharmacy Recent Developments
8 North America
  1. 8.1 North America Rapid Influenza Diagnostic Test (RIDT) Revenue (2021-2032)
  2. 8.2 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2032)
  3. 8.2.1 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026)
  4. 8.2.2 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032)
  5. 8.3 North America Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032)
  6. 8.4 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2032)
  7. 8.4.1 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026)
  8. 8.4.2 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032)
  9. 8.5 North America Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032)
  10. 8.6 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country
  11. 8.6.1 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021-2026)
  13. 8.6.3 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue (2021-2032)
  2. 9.2 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032)
  5. 9.3 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032)
  9. 9.5 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country
  11. 9.6.1 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Rapid Influenza Diagnostic Test (RIDT) Revenue (2021-2032)
  2. 10.2 China Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2032)
  3. 10.2.1 China Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026)
  4. 10.2.2 China Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032)
  5. 10.3 China Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032)
  6. 10.4 China Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2032)
  7. 10.4.1 China Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026)
  8. 10.4.2 China Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032)
  9. 10.5 China Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue (2021-2032)
  2. 11.2 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032)
  5. 11.3 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032)
  9. 11.5 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Country
  11. 11.6.1 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue (2021-2032)
  2. 12.2 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Country
  11. 12.6.1 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst